Progyny Stock Today
| PGNY Stock | USD 32.40 0.66 2.00% |
Performance0 of 100
| Odds Of DistressLess than 2
|
Progyny is trading at 32.40 as of the 24th of April 2024; that is -2 percent decrease since the beginning of the trading day. The stock's open price was 33.06. Progyny has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Progyny are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 25th of October 2019 | Category Healthcare | Classification Health Care |
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Progyny operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. The company has 96.11 M outstanding shares of which 6.53 M shares are at this time shorted by private and institutional investors with about 6.09 trading days to cover. More on Progyny
Moving against Progyny Stock
| 0.69 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
| 0.67 | AA | Alcoa Corp Financial Report 17th of July 2024 | PairCorr |
| 0.64 | MMM | 3M Company Earnings Call This Week | PairCorr |
| 0.63 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.61 | CAT | Caterpillar Earnings Call Tomorrow | PairCorr |
| 0.56 | WMT | Walmart Financial Report 16th of May 2024 | PairCorr |
| 0.54 | DD | Dupont De Nemours Earnings Call This Week | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 13th of May 2024
Progyny Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Progyny's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Progyny or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive Chairman | David Schlanger | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NASDAQ Composite, SP Midcap 400, NASDAQ Health Care, Health Care, Health Care Providers & Services, Health Information Services, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Progyny report their recommendations after researching Progyny's financial statements, talking to executives and customers, or listening in on Progyny's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Progyny. The Progyny consensus assessment is calculated by taking the average forecast from all of the analysts covering Progyny. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Progyny's financial statements, Progyny is performing exceptionally good at this time. It has a great probability to report excellent financial results in May. Financial strength of Progyny is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Progyny's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Progyny's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Progyny's financial leverage. It provides some insight into what part of Progyny's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Progyny (PGNY) is traded on NASDAQ Exchange in USA. It is located in 1359 Broadway, New York, NY, United States, 10018 and employs 563 people. Progyny is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.11 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Progyny's market, we take the total number of its shares issued and multiply it by Progyny's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Progyny conducts business under Health Care Providers & Services sector and is part of Health Care industry. The entity has 96.11 M outstanding shares of which 6.53 M shares are at this time shorted by private and institutional investors with about 6.09 trading days to cover.
Progyny currently holds about 122.39 M in cash with 188.81 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.33.
Check Progyny Probability Of Bankruptcy
Ownership AllocationProgyny has a total of 96.11 Million outstanding shares. The majority of Progyny outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Progyny to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Progyny. Please pay attention to any change in the institutional holdings of Progyny as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Progyny Ownership Details
Progyny Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Progyny jumping above the current price in 90 days from now is roughly 97.0%. The Progyny probability density function shows the probability of Progyny stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.3738 indicating as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Progyny will likely underperform. Additionally, progyny has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Progyny to move above the current price in 90 days from now is roughly 97.0 (This Progyny probability density function shows the probability of Progyny Stock to fall within a particular range of prices over 90 days) .
Progyny Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Progyny that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Progyny's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Progyny's value.| Instituion | Recorded On | Shares | |
| Thrivent Financial For Lutherans | 2023-12-31 | 2.2 M | |
| Riverbridge Partners Llc | 2023-12-31 | 2 M | |
| Geode Capital Management, Llc | 2023-12-31 | 1.8 M | |
| Macquarie Group Ltd | 2023-12-31 | 1.5 M | |
| Northern Trust Corp | 2023-12-31 | 1.4 M | |
| Owls Nest Partners Ia, Llc | 2023-12-31 | 1.4 M | |
| Nuveen Asset Management, Llc | 2023-12-31 | 1.4 M | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 1.4 M | |
| Principal Financial Group Inc | 2023-12-31 | 1.4 M | |
| Blackrock Inc | 2023-12-31 | 12.1 M | |
| Vanguard Group Inc | 2023-12-31 | 8.3 M |
Progyny Historical Income Statement
Progyny Income Statement is one of the three primary financial statements used for reporting Progyny's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Progyny revenue and expense. Progyny Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Progyny's Cost Of Revenue is fairly stable compared to the past year. Total Operating Expenses is likely to rise to about 185.4 M in 2024, whereas Interest Income is likely to drop slightly above 421.8 K in 2024. View More FundamentalsProgyny Stock Against Markets
Picking the right benchmark for Progyny stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Progyny stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Progyny is critical whether you are bullish or bearish towards Progyny at a given time. Please also check how Progyny's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Progyny without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Progyny Corporate Management
Elected by the shareholders, the Progyny's board of directors comprises two types of representatives: Progyny inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Progyny. The board's role is to monitor Progyny's management team and ensure that shareholders' interests are well served. Progyny's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Progyny's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Julie Stadlbauer | Ex Partnerships | Profile | |
| Katie Higgins | Chief Officer | Profile | |
| Risa Fisher | Chief Officer | Profile | |
| Cassandra Pratt | Senior People | Profile | |
| Peter Anevski | CEO Director | Profile | |
| Steven Leist | Chief Officer | Profile | |
| Michael Sturmer | President | Profile |
How to buy Progyny Stock?
Before investing in Progyny, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Progyny. To buy Progyny stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Progyny. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Progyny stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Progyny stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Progyny stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Progyny, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.
Already Invested in Progyny?
The danger of trading Progyny is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Progyny is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Progyny. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Progyny is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Progyny offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Progyny's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Progyny Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Progyny Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Progyny Stock analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Progyny's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Progyny. If investors know Progyny will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Progyny listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.645 | Earnings Share 0.62 | Revenue Per Share 11.456 | Quarterly Revenue Growth 0.26 | Return On Assets 0.0598 |
The market value of Progyny is measured differently than its book value, which is the value of Progyny that is recorded on the company's balance sheet. Investors also form their own opinion of Progyny's value that differs from its market value or its book value, called intrinsic value, which is Progyny's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progyny's market value can be influenced by many factors that don't directly affect Progyny's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Progyny's value and its price as these two are different measures arrived at by different means. Investors typically determine if Progyny is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progyny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.